Ironwood Pharmaceuticals (IRWD) Competitors $3.66 -0.12 (-3.17%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IRWD vs. LGND, GERN, MNKD, DVAX, BCRX, CLDX, NVAX, MYGN, INVA, and OPKShould you be buying Ironwood Pharmaceuticals stock or one of its competitors? The main competitors of Ironwood Pharmaceuticals include Ligand Pharmaceuticals (LGND), Geron (GERN), MannKind (MNKD), Dynavax Technologies (DVAX), BioCryst Pharmaceuticals (BCRX), Celldex Therapeutics (CLDX), Novavax (NVAX), Myriad Genetics (MYGN), Innoviva (INVA), and OPKO Health (OPK). These companies are all part of the "biotechnology" industry. Ironwood Pharmaceuticals vs. Ligand Pharmaceuticals Geron MannKind Dynavax Technologies BioCryst Pharmaceuticals Celldex Therapeutics Novavax Myriad Genetics Innoviva OPKO Health Ironwood Pharmaceuticals (NASDAQ:IRWD) and Ligand Pharmaceuticals (NASDAQ:LGND) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, community ranking, earnings, valuation and analyst recommendations. Is IRWD or LGND more profitable? Ligand Pharmaceuticals has a net margin of 29.68% compared to Ironwood Pharmaceuticals' net margin of -0.65%. Ligand Pharmaceuticals' return on equity of 4.95% beat Ironwood Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Ironwood Pharmaceuticals-0.65% -0.96% 0.74% Ligand Pharmaceuticals 29.68%4.95%4.39% Do analysts prefer IRWD or LGND? Ironwood Pharmaceuticals currently has a consensus target price of $10.40, suggesting a potential upside of 184.15%. Ligand Pharmaceuticals has a consensus target price of $147.00, suggesting a potential upside of 31.38%. Given Ironwood Pharmaceuticals' higher possible upside, equities analysts clearly believe Ironwood Pharmaceuticals is more favorable than Ligand Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ironwood Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Ligand Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor IRWD or LGND? In the previous week, Ironwood Pharmaceuticals had 6 more articles in the media than Ligand Pharmaceuticals. MarketBeat recorded 9 mentions for Ironwood Pharmaceuticals and 3 mentions for Ligand Pharmaceuticals. Ligand Pharmaceuticals' average media sentiment score of 0.95 beat Ironwood Pharmaceuticals' score of 0.80 indicating that Ligand Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ironwood Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Ligand Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, IRWD or LGND? Ligand Pharmaceuticals has lower revenue, but higher earnings than Ironwood Pharmaceuticals. Ironwood Pharmaceuticals is trading at a lower price-to-earnings ratio than Ligand Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIronwood Pharmaceuticals$442.73M1.32-$1.00B-$0.03-122.00Ligand Pharmaceuticals$131.31M16.10$52.15M$2.5144.58 Does the MarketBeat Community believe in IRWD or LGND? Ligand Pharmaceuticals received 42 more outperform votes than Ironwood Pharmaceuticals when rated by MarketBeat users. Likewise, 70.77% of users gave Ligand Pharmaceuticals an outperform vote while only 61.08% of users gave Ironwood Pharmaceuticals an outperform vote. CompanyUnderperformOutperformIronwood PharmaceuticalsOutperform Votes51061.08% Underperform Votes32538.92% Ligand PharmaceuticalsOutperform Votes55270.77% Underperform Votes22829.23% Which has more volatility and risk, IRWD or LGND? Ironwood Pharmaceuticals has a beta of 0.34, suggesting that its stock price is 66% less volatile than the S&P 500. Comparatively, Ligand Pharmaceuticals has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Do insiders & institutionals believe in IRWD or LGND? 91.3% of Ligand Pharmaceuticals shares are held by institutional investors. 12.9% of Ironwood Pharmaceuticals shares are held by company insiders. Comparatively, 5.9% of Ligand Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryLigand Pharmaceuticals beats Ironwood Pharmaceuticals on 14 of the 18 factors compared between the two stocks. Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRWD vs. The Competition Export to ExcelMetricIronwood PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$633.71M$6.37B$5.23B$8.96BDividend YieldN/A2.94%5.13%4.04%P/E Ratio-122.009.4187.2917.29Price / Sales1.32310.261,255.8979.02Price / CashN/A61.4443.8235.97Price / Book-1.666.055.324.79Net Income-$1.00B$154.90M$122.78M$225.07M7 Day Performance-7.58%-1.72%-0.19%1.51%1 Month Performance5.78%2.69%3.72%4.68%1 Year Performance-69.95%2.78%27.31%20.92% Ironwood Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRWDIronwood Pharmaceuticals4.4292 of 5 stars$3.66-3.2%$10.40+184.2%-70.4%$633.71M$442.73M-122.00220Short Interest ↓News CoverageLGNDLigand Pharmaceuticals4.9592 of 5 stars$104.86-1.3%$147.00+40.2%+57.9%$1.98B$152.42M41.7880News CoverageGERNGeron3.7244 of 5 stars$2.95-6.9%$7.25+145.8%+50.5%$1.78B$29.48M-9.2270MNKDMannKind3.9469 of 5 stars$6.13+0.7%$9.07+48.0%+83.2%$1.69B$267.20M87.57400Short Interest ↓DVAXDynavax Technologies4.5462 of 5 stars$12.50-1.0%$22.00+76.0%-11.0%$1.64B$260.81M96.16350Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownBCRXBioCryst Pharmaceuticals4.4287 of 5 stars$7.91+3.1%$15.17+91.7%+25.0%$1.64B$412.58M-12.97530Short Interest ↓CLDXCelldex Therapeutics1.2839 of 5 stars$24.39+0.2%$62.25+155.2%-40.1%$1.62B$9.98M-9.49150Short Interest ↑Positive NewsNVAXNovavax4.019 of 5 stars$8.54-8.3%$17.83+108.8%+99.8%$1.37B$847.25M-3.781,990MYGNMyriad Genetics4.0894 of 5 stars$14.07-5.1%$24.27+72.5%-38.1%$1.28B$823.60M-10.822,700Analyst ForecastShort Interest ↑News CoverageINVAInnoviva1.6441 of 5 stars$17.54+1.5%N/A+15.4%$1.10B$352.75M25.42100Positive NewsOPKOPKO Health4.4641 of 5 stars$1.53+4.1%$2.75+79.7%+49.1%$1.04B$863.50M-8.053,930Analyst DowngradeInsider TradeNews Coverage Related Companies and Tools Related Companies Ligand Pharmaceuticals Alternatives Geron Alternatives MannKind Alternatives Dynavax Technologies Alternatives BioCryst Pharmaceuticals Alternatives Celldex Therapeutics Alternatives Novavax Alternatives Myriad Genetics Alternatives Innoviva Alternatives OPKO Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRWD) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRWD Stock Alerts